GSK-J4 hydrochloride
1797983-09-5
95%
2026-07-13
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Description
ProductName GSK-J4 hydrochloride Cat No CEI-0547 Description Cell-permeable. An ethyl ester derivative of the JMJD3 selective histone demethylase inhibitor GSK-J1 (IC50> 50 µM in vitro. When administered to human primary macrophages, GSK-J4 can reduce lipopolysaccharide (LPS)-induced proinflammatory cytokine production, most notably including that of TNFα (IC50 = 9 µM). Appearance Liquid Product Overview Histone demethylase JMJD3/UTX inhibitor CAS No 1797983-09-5 Molecular Weight 540.54 Purity >95% by HPLC Storage -20 centigrade Targets KDM6B Molecular Formula C24H27N5O2 . HCL Chemical Name Ethyl 3-((6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2--(pyridin-2- yl)pyrimidin-4-yl)amino)propanoate, monohydrochloride Shipping Conditions Gel pack category Heterocyclic Compound(c1111) cas_num 1797983-09-5 Basic Info-
Product Name:
GSK-J4 hydrochloride
CAS No.:1797983-09-5
Categories:
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product